About us

Nomic was founded to make biology easier to measure—and to enable scientists to extend lives by making proteomics accessible, scalable, and routine. Our story began at McGill University, where our co-founders and early team developed breakthrough technology that would change the way proteins are measured.

Today, Nomic is powered by our proprietary nELISA platform—an end-to-end technology that delivers high-throughput, quantitative, and affordable protein data at unprecedented scale. With the launch of Omni 1000, we are making the $50 proteome a reality, breaking down barriers that have limited the field for decades. For the first time, large-scale, quantitative proteomics is accessible to any scientist, supporting everything from drug discovery and translational research to AI-enabled therapeutic development.

Since our launch, we’ve partnered with leaders in pharma, biotech, and academia—including GlaxoSmithKline and the Broad Institute—...